Trade

Alpa Laboratories share price

High risk
  • 48%Low risk
  • 48%Moderate risk
  • 48%Balanced risk
  • 48%High risk
  • 48%Extreme risk
  • ₹101.70(0.00%)
    July 8, 2025 15:28:33 PM IST
    • NSE
    • BSE
  • Vol : 20.82K (NSE + BSE)
    Last 20 day avg : 35.31 K

Alpa Laboratories is trading 0.00% upper at Rs 101.70 as compared to its last closing price. Alpa Laboratories has been trading in the price range of 105.00 & 101.25. Alpa Laboratories has given -14.45% in this year & -3.07% in the last 5 days. Alpa Laboratories has TTM P/E ratio 11.07 as compared to the sector P/E of 23.19.The company posted a net profit of -2.12 Crores in its last quarter.Listed peers of Alpa Laboratories include Sanjivani Paranteral (0.99%), Natural Capsules (-2.26%), Alpa Laboratories (-%).The Mutual Fund holding in Alpa Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Alpa Laboratories was at 0.40% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 08, 2025, 09:18 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.26
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    10.93
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.79
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
101.25
Highest
105.00
52 week range
Lowest
82.20
Highest
144.60
Alpa Laboratories News
Alpa Laboratories Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is not profitable
    • financial-insightsThe company's revenue grew in March quarter by 69.10% from Rs 39.92 crore to Rs 23.61 crore, year-on-year
    • financial-insightsCompany has registered a loss of 2.12 cr vs a profit of 3.54 cr in the same quarter last year.
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Alpa Laboratories Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 111.09
  • R2
  • 117.85
  • R3
  • 125.84
Pivot103.10
  • S1
  • 96.34
  • S2
  • 88.35
  • S3
  • 81.59
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Alpa Laboratories Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sanjivani Paranteral
Moderately Bearish
219.950.99261.5232.506.77-13.92
Natural Capsules
Bearish
214.55-2.26221.26998.230.97-24.65
Alpa Laboratories
Neutral
101.70-215.3411.191.28--
Bafna Pharmaceuticals
Bullish
85.43-1.57202.0351.172.51-16.54
Coral Laboratories
Bearish
590.000.02210.798.491.040.34-
Alpa Laboratories Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Alpa Laboratories is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 57.29%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.05 percentage points from previous quarter
    • InsightsMutual Funds are not invested in this company.
    Alpa Laboratories Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-28Audited Results
    2025-02-13Quarterly Results & Others
    2024-11-14Quarterly Results
    2024-08-13Quarterly Results & A.G.M.
    2024-05-28Audited Results
    About the company Alpa Laboratories
    • IndustryBiotechnology & Drugs
    • ISININE385I01010
    • BSE Code532878
    • NSE CodeALPA
    Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
    • Management Info
    • Purushottam PatelChairman of the Board
    • Jayesh PatelChief Executive Officer
    • Bakulesh ShahChief Financial Officer
    • Srashti ChopraCompliance Officer and Company Secretary
    • Paresh ChawlaManaging Director, Director
    • Mahendra ChawlaWhole-Time Director
    • Pravin ShahWhole Time Director
    • Shitul ShahAdditional Director
    Alpa Laboratories Share Price FAQs

    Alpa Laboratories is trading at 101.70 as on Tue Jul 08 2025 09:58:33. This is 0.00% upper as compared to its previous closing price of 101.70.

    The market capitalization of Alpa Laboratories is 215.34 Cr as on Tue Jul 08 2025 09:58:33.

    The 52 wk high for Alpa Laboratories is 144.60 whereas the 52 wk low is 82.20

    Alpa Laboratories can be analyzed on the following key metrics -

    • TTM P/E: 11.07
    • Sector P/E: 23.19
    • Dividend Yield: 0.00%
    • D/E ratio: 0.00

    Alpa Laboratories reported a net profit of 19.50 Cr in 2025.

    Quick Links
    EQUITY QUICK LINKS
    Alpa Laboratories QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Alpa Laboratories share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.